Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

Author： Ingelman-Sundberg M. Oscarson M. McLellan R.A.

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.20, Iss.8, 1999-08, pp. : 342-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

By Ingelman-Sundberg Magnus

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 1, 2004-01 ,pp. : 89-104

Springer Publishing Company

Access to resources Recommend Favorite

Cancer treatment and pharmacogenetics of cytochrome P450 enzymes

By Schaik Ron

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 513-522

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Drugs Undergoing Polymorphic Metabolism by Human Cytochrome P450 2C9 and the Implication in Drug Development

Current Medicinal Chemistry, Vol. 18, Iss. 5, 2011-02 ,pp. : 667-713

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery

By Gelboin H.V. Krausz K.W. Gonzalez F.J. Yang T.J.

Trends in Pharmacological Sciences, Vol. 20, Iss. 11, 1999-11 ,pp. : 432-438

Elsevier

Access to resources Recommend Favorite

Expression, Function and Regulation of Mouse Cytochrome P450 Enzymes: Comparison With Human Cytochrome P450 Enzymes

Current Drug Metabolism, Vol. 10, Iss. 10, 2009-12 ,pp. : 1151-1183

Bentham Science Publishers

Access to resources Recommend Favorite